June 24, 2022
Life Sciences
  • The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) unanimously endorsed Moderna’s vaccine for use in those between the ages of 6 and 17. Previously, the only COVID-19 vaccine authorized for use in children between 6 and 17 was Pfizer’s two-dose mRNA vaccine. CDC Director Rochelle Walensky is likely to sign off on the committee’s recommendation. (Articles here, here, here, here, and here)